Randomised phase III trials of cancer prevention drugs: a systematic review and prediction of trial success

A. Xu-Vuillard, B. Duso, B. Arun, J. Balmana, A. De Censi, N. Iyengar, N. Pashayan, C. Yu, D. Munoz-Espin, R. Fitzgerald, B. Ma, G. Kapetanakis, C. Turnbull, S. Halabi, S. Delaloge, B. Duso, B. Arun, J. Balmana, A. De Censi, R. Fitzgerald, N. Iyengar, N. Pashayan, D. Munoz-Espin, B. Ma, G. Kapetanakis, C. Turnbull, S. Delaloge

Open source

DOI: 10.1016/j.esmoop.2026.108359
Published: 2026-10
Container: ESMO Open
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.esmoop.2026.108359,
  title = {Randomised phase III trials of cancer prevention drugs: a systematic review and prediction of trial success},
  author = {A. Xu-Vuillard and B. Duso and B. Arun and J. Balmana and A. De Censi and N. Iyengar and N. Pashayan and C. Yu and D. Munoz-Espin and R. Fitzgerald and B. Ma and G. Kapetanakis and C. Turnbull and S. Halabi and S. Delaloge and B. Duso and B. Arun and J. Balmana and A. De Censi and R. Fitzgerald and N. Iyengar and N. Pashayan and D. Munoz-Espin and B. Ma and G. Kapetanakis and C. Turnbull and S. Delaloge},
  year = {2026},
  journal = {ESMO Open},
  doi = {10.1016/j.esmoop.2026.108359},
  url = {https://doi.org/10.1016/j.esmoop.2026.108359}
}

RIS

TY  - JOUR
TI  - Randomised phase III trials of cancer prevention drugs: a systematic review and prediction of trial success
AU  - A. Xu-Vuillard
AU  - B. Duso
AU  - B. Arun
AU  - J. Balmana
AU  - A. De Censi
AU  - N. Iyengar
AU  - N. Pashayan
AU  - C. Yu
AU  - D. Munoz-Espin
AU  - R. Fitzgerald
AU  - B. Ma
AU  - G. Kapetanakis
AU  - C. Turnbull
AU  - S. Halabi
AU  - S. Delaloge
AU  - B. Duso
AU  - B. Arun
AU  - J. Balmana
AU  - A. De Censi
AU  - R. Fitzgerald
AU  - N. Iyengar
AU  - N. Pashayan
AU  - D. Munoz-Espin
AU  - B. Ma
AU  - G. Kapetanakis
AU  - C. Turnbull
AU  - S. Delaloge
PY  - 2026
JO  - ESMO Open
DO  - 10.1016/j.esmoop.2026.108359
UR  - https://doi.org/10.1016/j.esmoop.2026.108359
ER  -

APA

Xu-Vuillard, A., Duso, B., Arun, B., Balmana, J., Censi, A. D., Iyengar, N., Pashayan, N., Yu, C., Munoz-Espin, D., Fitzgerald, R., Ma, B., Kapetanakis, G., Turnbull, C., Halabi, S., Delaloge, S., Duso, B., Arun, B., Balmana, J., Censi, A. D., Fitzgerald, R., Iyengar, N., Pashayan, N., Munoz-Espin, D., Ma, B., Kapetanakis, G., Turnbull, C., & Delaloge, S. (2026). Randomised phase III trials of cancer prevention drugs: a systematic review and prediction of trial success. ESMO Open. https://doi.org/10.1016/j.esmoop.2026.108359

Source records

crossref · retrieved 2026-09-26T09:40:16.356Z